Answers are grounded in this paper and cite their sources.
Background: Teletherapy has become an increasingly common delivery format for adolescent mental healthcare, particularly since the COVID-19 pandemic. Given adolescents’ distinct developmental characteristics, its effectiveness requires evaluation against in-person treatment and alternative remote formats. The objective was to map the randomized controlled trial (RCT) evidence on teletherapy for adolescent mental health and to conduct a quantitative synthesis where the evidence permits. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidance, six databases were searched for RCTs published from 2014 onward that evaluated therapist-delivered remote psychotherapy for adolescents (13–18 years) with diagnosed mental health conditions, compared with face-to-face treatment, an alternative teletherapy format, or a waitlist or minimal-contact control. Quantitative synthesis was stratified by comparator type. Results: Eighteen RCTs across eight diagnostic categories were included. Six compared teletherapy with face-to-face treatment, six compared two remote formats, and six used only waitlist or minimal-contact controls. Among face-to-face comparisons, two obsessive-compulsive disorder trials met noninferiority margins, two anxiety trials nonsignificantly favored face-to-face treatment ( g = −0.54 and −0.45), and single tic-disorder and insomnia trials found no clear difference. Teletherapy was superior to waitlist or minimal-contact control for anxiety ( k = 6, g = 1.56, 95% confidence interval [CI]: 0.75–2.38) and depression ( k = 5, g = 1.14, 95% CI: 0.64–1.64). Risk of bias was low in 3 of 18 trials. Conclusions: Teletherapy improves adolescent anxiety and depression relative to waitlist or minimal-contact controls, although the size of the benefit is uncertain. Face-to-face comparisons are few, and their findings differ by condition, so equivalence to in-person care cannot yet be established. Condition-specific trials with face-to-face comparators are needed.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: